<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>BRII BIOSCIENCES 1 RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Sun, 03 May 2026 18:35:40 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/brii%5Fbiosciences%5F1%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>BRII BIOSCIENCES 1 RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>Brii Biosciences Announces Publication of Phase 2 ENSURE Study Results in Nature Medicine</title><pubDate>Fri, 07 Nov 2025 14:30:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/brii-biosciences-announces-publication-of-phase-2-ensure-study-results-in-nature-medicine-15220287</link><description><![CDATA[<p><ul type="disc" xmlns="http://www.w3.org/1999/xhtml"><li><i>Findings provide scientific insights into the contribution of small interfering RNA (siRNA) and therapeutic vaccination towards the HBV functional cure strategy</i></li></ul><p xmlns="http://www.w3.org/1999/xhtml"><span  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/brii-biosciences-announces-publication-of-phase-2-ensure-study-results-in-nature-medicine-15220287</guid></item><item><title>Brii Biosciences Announces Publication of Phase 2 ENSURE Study Results in Nature Medicine</title><pubDate>Fri, 07 Nov 2025 14:30:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/brii-biosciences-announces-publication-of-phase-2-ensure-study-results-in-nature-medicine-15220290</link><description><![CDATA[<p><ul type="disc" xmlns="http://www.w3.org/1999/xhtml"><li><i>Findings provide scientific insights into the contribution of small interfering RNA (siRNA) and therapeutic vaccination towards the HBV functional cure strategy</i></li></ul><p xmlns="http://www.w3.org/1999/xhtml"><span  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/brii-biosciences-announces-publication-of-phase-2-ensure-study-results-in-nature-medicine-15220290</guid></item></channel></rss>
